|
NCRAF Pharm/Bio & Device Workshops
Virtual Event - Webinar Only Durham, NC 27701 USA
Tuesday, June 09, 2026, 6:00 PM - 8:00 PM EDT
Category: RAC Workshop
The workshops will have live sessions every Tuesday evening, 6 -8 pm US Eastern time; starting June 9, 2026 and running weekly through October 6, 2026; see the confirmation email for all session dates and topics.
ALL sessions will be REMOTE; held via Zoom.
The Zoom meeting info can be found in the confirmation email.
2026 Workshops Agenda (May 1, 2026)
|
Lecture topic
|
Section
|
Lecture date
|
Speaker
|
|
Introduction
|
Both
|
June 9
|
Maria Oyaski
|
|
Regulatory Authority Meetings
|
Both
|
June 16
|
Kevin Barber
|
|
Preclinical Development and GLPs
|
Both
|
June 23
|
Brenda Faiola
|
|
Clinical Protocols and Clinical Development Plans
|
Both
|
June 30
|
Matthew Barnes
|
|
Good Clinical Practices
|
Both
|
July 7
|
David Jensen
|
|
|
|
|
|
|
Biologics: Part 1 - the basics
|
Pharma/ Biologics
|
July 14
|
Maria Oyaski
|
|
Device Classification and Regulatory Controls
|
Devices
|
July 14
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
CMC (drugs & Biologics)
|
Pharma/ Biologics
|
July 21
|
Olu Aloba
|
|
Medical Device Design Process (Design Controls)
|
Devices
|
July 21
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
INDs, IMPDs, CTAs, & CTXs
|
Pharma/ Biologics
|
July 28
|
Kathleen Candando
|
|
IDEs, etc (ex-US device clinical trial submissions)
|
Devices
|
July 28
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
Combination Products
|
Both
|
August 4
|
Shilpa Gampa
|
|
Pharmacovigilance
|
Both
|
August 11
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
Biologics: Part 2 – Biosimilars, Vaccines, Advanced Therapy Medicinal Products
|
Pharma/ Biologics
|
August 18
|
Maria Oyaski
|
|
Post-Market Activities (e.g. label changes, post-market commitments, maintain/update files)
|
Devices
|
August 18
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
NDAs/BLAs, MAAs, JNDAs, NDSs
|
Pharma/ Biologics
|
August 25
|
Sheila Plant
|
|
510(k)s, PMAs, Canada, EU (CE mark, etc), Int.
|
Devices
|
August 25
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
Pediatric, Orphan Product and Expanded Access Development for Rare Diseases
|
Pharma/ Biologics
|
September 1
|
Erin O’Reilly
|
|
Special Programs (HDEs, Special Access, etc)
|
Devices
|
September 1
|
Pending Speaker Confirmation
|
|
|
|
|
|
|
Pharmaceuticals, Generics, and OTC Drugs
|
Pharma/ Biologics
|
September 8
|
Catherine Maher
|
|
In Vitro Diagnostics, “LDTs”/CLIA, Companion Diagnostics
|
Devices
|
September 8
|
Stefan Burde (EU)
David Jensen (US)
|
|
|
|
|
|
|
No Presentation – RAPS Convergence in Charlotte, NC
|
|
September 15
|
N/A
|
|
|
|
|
|
|
Prescription Product Labeling
|
Both
|
September 22
|
Kamana Singh
|
|
Compliance, Regulatory Inspections, and Enforcement
|
Both
|
September 29
|
Drew Barlow
|
|
Post Marketing
|
Both
|
October 6
|
Patricia Termini
|
|
|
|
|
|
Contact: [email protected]
|